iShares Genomics Immnlgy & Hlthcr ETF IDNA

Medalist Rating as of | See iShares Investment Hub

Morningstar’s Analysis IDNA

Will IDNA outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

A drop in its Process Pillar rating is the primary driver of iShares Genomics Immnlgy& Hlthcr ETF's downgrade to a Morningstar Medalist Rating of Bronze from Silver.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The portfolio maintains a cost advantage over competitors, priced within the least expensive fee quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings IDNA

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 46.7
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

BeiGene Ltd Ordinary Shares

5.60 7.9 Mil
Healthcare

Gilead Sciences Inc

5.13 7.2 Mil
Healthcare

Roche Holding AG

4.75 6.7 Mil
Healthcare

Exelixis Inc

4.71 6.6 Mil
Healthcare

BioNTech SE ADR

4.68 6.6 Mil
Healthcare

Sanofi SA

4.64 6.5 Mil
Healthcare

Incyte Corp

4.42 6.2 Mil
Healthcare

Revolution Medicines Inc Ordinary Shares

4.35 6.1 Mil
Healthcare

Takeda Pharmaceutical Co Ltd

4.28 6.0 Mil
Healthcare

Regeneron Pharmaceuticals Inc

4.13 5.8 Mil
Healthcare

Sponsor Center